These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20628651)

  • 1. A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.
    Kurz A; Double KL; Lastres-Becker I; Tozzi A; Tantucci M; Bockhart V; Bonin M; García-Arencibia M; Nuber S; Schlaudraff F; Liss B; Fernández-Ruiz J; Gerlach M; Wüllner U; Lüddens H; Calabresi P; Auburger G; Gispert S
    PLoS One; 2010 Jul; 5(7):e11464. PubMed ID: 20628651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice.
    Tozzi A; Costa C; Siliquini S; Tantucci M; Picconi B; Kurz A; Gispert S; Auburger G; Calabresi P
    Neurobiol Aging; 2012 Aug; 33(8):1792-9. PubMed ID: 21684039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dopamine transmission is subtly modified in human A53Tα-synuclein overexpressing mice.
    Platt NJ; Gispert S; Auburger G; Cragg SJ
    PLoS One; 2012; 7(5):e36397. PubMed ID: 22570709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP.
    Kurz A; May C; Schmidt O; Müller T; Stephan C; Meyer HE; Gispert S; Auburger G; Marcus K
    J Neural Transm (Vienna); 2012 Mar; 119(3):297-312. PubMed ID: 21960009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine.
    Brehm N; Bez F; Carlsson T; Kern B; Gispert S; Auburger G; Cenci MA
    Mol Neurobiol; 2015 Dec; 52(3):1152-1164. PubMed ID: 25307288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons.
    Cabeza-Arvelaiz Y; Fleming SM; Richter F; Masliah E; Chesselet MF; Schiestl RH
    Mol Neurodegener; 2011 Dec; 6():83. PubMed ID: 22165993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein.
    Watson JB; Hatami A; David H; Masliah E; Roberts K; Evans CE; Levine MS
    Neuroscience; 2009 Mar; 159(2):501-13. PubMed ID: 19361478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
    Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
    J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.
    Kuo YM; Li Z; Jiao Y; Gaborit N; Pani AK; Orrison BM; Bruneau BG; Giasson BI; Smeyne RJ; Gershon MD; Nussbaum RL
    Hum Mol Genet; 2010 May; 19(9):1633-50. PubMed ID: 20106867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.
    Taylor TN; Potgieter D; Anwar S; Senior SL; Janezic S; Threlfell S; Ryan B; Parkkinen L; Deltheil T; Cioroch M; Livieratos A; Oliver PL; Jennings KA; Davies KE; Ansorge O; Bannerman DM; Cragg SJ; Wade-Martins R
    Neurobiol Dis; 2014 Feb; 62():193-207. PubMed ID: 24121116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function.
    Oaks AW; Frankfurt M; Finkelstein DI; Sidhu A
    PLoS One; 2013; 8(4):e60378. PubMed ID: 23560093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains.
    Piltonen M; Savolainen M; Patrikainen S; Baekelandt V; Myöhänen TT; Männistö PT
    Neuroscience; 2013 Feb; 231():157-68. PubMed ID: 23219665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.
    Peneder TM; Scholze P; Berger ML; Reither H; Heinze G; Bertl J; Bauer J; Richfield EK; Hornykiewicz O; Pifl C
    Neuroscience; 2011 Apr; 180():280-92. PubMed ID: 21333719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein.
    Lam HA; Wu N; Cely I; Kelly RL; Hean S; Richter F; Magen I; Cepeda C; Ackerson LC; Walwyn W; Masliah E; Chesselet MF; Levine MS; Maidment NT
    J Neurosci Res; 2011 Jul; 89(7):1091-102. PubMed ID: 21488084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice.
    Al-Wandi A; Ninkina N; Millership S; Williamson SJ; Jones PA; Buchman VL
    Neurobiol Aging; 2010 May; 31(5):796-804. PubMed ID: 19097673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.